ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GLP-1 Injection Market Research Report 2024
Published Date: December 2024
|
Report Code: QYRE-Auto-19I18819
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global GLP 1 Injection Market Research Report 2024
BUY CHAPTERS

Global GLP-1 Injection Market Research Report 2024

Code: QYRE-Auto-19I18819
Report
December 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
L
Novo Nordisk
Eli Lilly
Huadong Medicine
Innovent Biologics
Hengrui Medicine
Borui Pharmaceuticals
Shanghai Benemae Biopharmaceuticals Co., Ltd.
CSPC Pharmaceutical Group
Hansoh Pharmaceuticals
Gan & Lee Pharmaceuticals
Sihuan Pharmaceuticals
Wanbang Biopharma
IMEIK
Zhengda Tianqing
PegBio Co., Ltd
Hongyun Huaning

GLP-1 Injection Market Size

The global market for GLP-1 Injection was valued at US$ 982 million in the year 2023 and is projected to reach a revised size of US$ 2224 million by 2030, growing at a CAGR of 12.4% during the forecast period.

GLP-1 Injection Market

GLP-1 Injection Market

GLP-1 (glucagon-like peptide-1) injection is an injectable drug developed based on GLP-1 or its analogs. GLP-1 is a hormone secreted by intestinal L cells and has multiple physiological effects in the body, including promoting insulin secretion, inhibiting glucagon secretion, slowing gastric emptying, suppressing appetite and reducing food intake. GLP-1 injection is mainly used to treat type 2 diabetes and obesity by simulating or enhancing these physiological effects of GLP-1.
North American market for GLP-1 Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for GLP-1 Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of GLP-1 Injection include Novo Nordisk, Eli Lilly, Huadong Medicine, Innovent Biologics, Hengrui Medicine, Borui Pharmaceuticals, Shanghai Benemae Biopharmaceuticals Co., Ltd., CSPC Pharmaceutical Group, Hansoh Pharmaceuticals, Gan & Lee Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GLP-1 Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 Injection.
The GLP-1 Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GLP-1 Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP-1 Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of GLP-1 Injection Market Report

Report Metric Details
Report Name GLP-1 Injection Market
Accounted market size in year US$ 982 million
Forecasted market size in 2030 US$ 2224 million
CAGR 12.4%
Base Year year
Forecasted years 2025 - 2030
by Type
by Application
  • Diabetes
  • Obesity
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, Eli Lilly, Huadong Medicine, Innovent Biologics, Hengrui Medicine, Borui Pharmaceuticals, Shanghai Benemae Biopharmaceuticals Co., Ltd., CSPC Pharmaceutical Group, Hansoh Pharmaceuticals, Gan & Lee Pharmaceuticals, Sihuan Pharmaceuticals, Wanbang Biopharma, Imeik, Zhengda Tianqing, Hongyun Huaning, Pegbio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GLP-1 Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GLP-1 Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is GLP-1 Injection Market growing?

Ans: The GLP-1 Injection Market witnessing a CAGR of 12.4% during the forecast period 2025-2030.

What is the GLP-1 Injection Market size in 2030?

Ans: The GLP-1 Injection Market size in 2030 will be US$ 2224 million.

Who are the main players in the GLP-1 Injection Market report?

Ans: The main players in the GLP-1 Injection Market are Novo Nordisk, Eli Lilly, Huadong Medicine, Innovent Biologics, Hengrui Medicine, Borui Pharmaceuticals, Shanghai Benemae Biopharmaceuticals Co., Ltd., CSPC Pharmaceutical Group, Hansoh Pharmaceuticals, Gan & Lee Pharmaceuticals, Sihuan Pharmaceuticals, Wanbang Biopharma, Imeik, Zhengda Tianqing, Hongyun Huaning, Pegbio

What are the Application segmentation covered in the GLP-1 Injection Market report?

Ans: The Applications covered in the GLP-1 Injection Market report are Diabetes, Obesity, Others

What are the Type segmentation covered in the GLP-1 Injection Market report?

Ans: The Types covered in the GLP-1 Injection Market report are Liraglutide, Semaglutide, Tirzepatide, Benaglutide, Others

Recommended Reports

GLP-1 and Analogues

GLP-1 for Weight Loss

Diabetes Therapeutics

1 GLP-1 Injection Market Overview
1.1 Product Definition
1.2 GLP-1 Injection by Type
1.2.1 Global GLP-1 Injection Market Value Comparison by Type (2024-2030)
1.2.2 Liraglutide
1.2.3 Semaglutide
1.2.4 Tirzepatide
1.2.5 Benaglutide
1.2.6 Others
1.3 GLP-1 Injection by Application
1.3.1 Global GLP-1 Injection Market Value by Application (2024-2030)
1.3.2 Diabetes
1.3.3 Obesity
1.3.4 Others
1.4 Global GLP-1 Injection Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Injection Revenue 2019-2030
1.4.2 Global GLP-1 Injection Sales 2019-2030
1.4.3 Global GLP-1 Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 GLP-1 Injection Market Competition by Manufacturers
2.1 Global GLP-1 Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global GLP-1 Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global GLP-1 Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of GLP-1 Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GLP-1 Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP-1 Injection, Product Type & Application
2.7 Global Key Manufacturers of GLP-1 Injection, Date of Enter into This Industry
2.8 Global GLP-1 Injection Market Competitive Situation and Trends
2.8.1 Global GLP-1 Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GLP-1 Injection Players Market Share by Revenue
2.8.3 Global GLP-1 Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Injection Market Scenario by Region
3.1 Global GLP-1 Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global GLP-1 Injection Sales by Region: 2019-2030
3.2.1 Global GLP-1 Injection Sales by Region: 2019-2024
3.2.2 Global GLP-1 Injection Sales by Region: 2025-2030
3.3 Global GLP-1 Injection Revenue by Region: 2019-2030
3.3.1 Global GLP-1 Injection Revenue by Region: 2019-2024
3.3.2 Global GLP-1 Injection Revenue by Region: 2025-2030
3.4 North America GLP-1 Injection Market Facts & Figures by Country
3.4.1 North America GLP-1 Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America GLP-1 Injection Sales by Country (2019-2030)
3.4.3 North America GLP-1 Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Injection Market Facts & Figures by Country
3.5.1 Europe GLP-1 Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe GLP-1 Injection Sales by Country (2019-2030)
3.5.3 Europe GLP-1 Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Injection Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific GLP-1 Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific GLP-1 Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Injection Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America GLP-1 Injection Sales by Country (2019-2030)
3.7.3 Latin America GLP-1 Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa GLP-1 Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa GLP-1 Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Injection Sales by Type (2019-2030)
4.1.1 Global GLP-1 Injection Sales by Type (2019-2024)
4.1.2 Global GLP-1 Injection Sales by Type (2025-2030)
4.1.3 Global GLP-1 Injection Sales Market Share by Type (2019-2030)
4.2 Global GLP-1 Injection Revenue by Type (2019-2030)
4.2.1 Global GLP-1 Injection Revenue by Type (2019-2024)
4.2.2 Global GLP-1 Injection Revenue by Type (2025-2030)
4.2.3 Global GLP-1 Injection Revenue Market Share by Type (2019-2030)
4.3 Global GLP-1 Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global GLP-1 Injection Sales by Application (2019-2030)
5.1.1 Global GLP-1 Injection Sales by Application (2019-2024)
5.1.2 Global GLP-1 Injection Sales by Application (2025-2030)
5.1.3 Global GLP-1 Injection Sales Market Share by Application (2019-2030)
5.2 Global GLP-1 Injection Revenue by Application (2019-2030)
5.2.1 Global GLP-1 Injection Revenue by Application (2019-2024)
5.2.2 Global GLP-1 Injection Revenue by Application (2025-2030)
5.2.3 Global GLP-1 Injection Revenue Market Share by Application (2019-2030)
5.3 Global GLP-1 Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk GLP-1 Injection Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly GLP-1 Injection Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Huadong Medicine
6.3.1 Huadong Medicine Company Information
6.3.2 Huadong Medicine Description and Business Overview
6.3.3 Huadong Medicine GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Huadong Medicine GLP-1 Injection Product Portfolio
6.3.5 Huadong Medicine Recent Developments/Updates
6.4 Innovent Biologics
6.4.1 Innovent Biologics Company Information
6.4.2 Innovent Biologics Description and Business Overview
6.4.3 Innovent Biologics GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Innovent Biologics GLP-1 Injection Product Portfolio
6.4.5 Innovent Biologics Recent Developments/Updates
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Company Information
6.5.2 Hengrui Medicine Description and Business Overview
6.5.3 Hengrui Medicine GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hengrui Medicine GLP-1 Injection Product Portfolio
6.5.5 Hengrui Medicine Recent Developments/Updates
6.6 Borui Pharmaceuticals
6.6.1 Borui Pharmaceuticals Company Information
6.6.2 Borui Pharmaceuticals Description and Business Overview
6.6.3 Borui Pharmaceuticals GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Borui Pharmaceuticals GLP-1 Injection Product Portfolio
6.6.5 Borui Pharmaceuticals Recent Developments/Updates
6.7 Shanghai Benemae Biopharmaceuticals Co., Ltd.
6.7.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
6.7.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. Description and Business Overview
6.7.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Product Portfolio
6.7.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments/Updates
6.8 CSPC Pharmaceutical Group
6.8.1 CSPC Pharmaceutical Group Company Information
6.8.2 CSPC Pharmaceutical Group Description and Business Overview
6.8.3 CSPC Pharmaceutical Group GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CSPC Pharmaceutical Group GLP-1 Injection Product Portfolio
6.8.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.9 Hansoh Pharmaceuticals
6.9.1 Hansoh Pharmaceuticals Company Information
6.9.2 Hansoh Pharmaceuticals Description and Business Overview
6.9.3 Hansoh Pharmaceuticals GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hansoh Pharmaceuticals GLP-1 Injection Product Portfolio
6.9.5 Hansoh Pharmaceuticals Recent Developments/Updates
6.10 Gan & Lee Pharmaceuticals
6.10.1 Gan & Lee Pharmaceuticals Company Information
6.10.2 Gan & Lee Pharmaceuticals Description and Business Overview
6.10.3 Gan & Lee Pharmaceuticals GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Gan & Lee Pharmaceuticals GLP-1 Injection Product Portfolio
6.10.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
6.11 Sihuan Pharmaceuticals
6.11.1 Sihuan Pharmaceuticals Company Information
6.11.2 Sihuan Pharmaceuticals Description and Business Overview
6.11.3 Sihuan Pharmaceuticals GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sihuan Pharmaceuticals GLP-1 Injection Product Portfolio
6.11.5 Sihuan Pharmaceuticals Recent Developments/Updates
6.12 Wanbang Biopharma
6.12.1 Wanbang Biopharma Company Information
6.12.2 Wanbang Biopharma Description and Business Overview
6.12.3 Wanbang Biopharma GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Wanbang Biopharma GLP-1 Injection Product Portfolio
6.12.5 Wanbang Biopharma Recent Developments/Updates
6.13 Imeik
6.13.1 Imeik Company Information
6.13.2 Imeik Description and Business Overview
6.13.3 Imeik GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Imeik GLP-1 Injection Product Portfolio
6.13.5 Imeik Recent Developments/Updates
6.14 Zhengda Tianqing
6.14.1 Zhengda Tianqing Company Information
6.14.2 Zhengda Tianqing Description and Business Overview
6.14.3 Zhengda Tianqing GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zhengda Tianqing GLP-1 Injection Product Portfolio
6.14.5 Zhengda Tianqing Recent Developments/Updates
6.15 Hongyun Huaning
6.15.1 Hongyun Huaning Company Information
6.15.2 Hongyun Huaning Description and Business Overview
6.15.3 Hongyun Huaning GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Hongyun Huaning GLP-1 Injection Product Portfolio
6.15.5 Hongyun Huaning Recent Developments/Updates
6.16 Pegbio
6.16.1 Pegbio Company Information
6.16.2 Pegbio Description and Business Overview
6.16.3 Pegbio GLP-1 Injection Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Pegbio GLP-1 Injection Product Portfolio
6.16.5 Pegbio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Injection Industry Chain Analysis
7.2 GLP-1 Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Injection Production Mode & Process
7.4 GLP-1 Injection Sales and Marketing
7.4.1 GLP-1 Injection Sales Channels
7.4.2 GLP-1 Injection Distributors
7.5 GLP-1 Injection Customers
8 GLP-1 Injection Market Dynamics
8.1 GLP-1 Injection Industry Trends
8.2 GLP-1 Injection Market Drivers
8.3 GLP-1 Injection Market Challenges
8.4 GLP-1 Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
L
Novo Nordisk
Eli Lilly
Huadong Medicine
Innovent Biologics
Hengrui Medicine
Borui Pharmaceuticals
Shanghai Benemae Biopharmaceuticals Co., Ltd.
CSPC Pharmaceutical Group
Hansoh Pharmaceuticals
Gan & Lee Pharmaceuticals
Sihuan Pharmaceuticals
Wanbang Biopharma
IMEIK
Zhengda Tianqing
PegBio Co., Ltd
Hongyun Huaning
List of Tables
 Table 1. Global GLP-1 Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global GLP-1 Injection Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global GLP-1 Injection Market Competitive Situation by Manufacturers in 2023
 Table 4. Global GLP-1 Injection Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global GLP-1 Injection Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global GLP-1 Injection Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global GLP-1 Injection Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market GLP-1 Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of GLP-1 Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GLP-1 Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GLP-1 Injection, Product Type & Application
 Table 12. Global Key Manufacturers of GLP-1 Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GLP-1 Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Injection as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GLP-1 Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global GLP-1 Injection Sales by Region (2019-2024) & (K Units)
 Table 18. Global GLP-1 Injection Sales Market Share by Region (2019-2024)
 Table 19. Global GLP-1 Injection Sales by Region (2025-2030) & (K Units)
 Table 20. Global GLP-1 Injection Sales Market Share by Region (2025-2030)
 Table 21. Global GLP-1 Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global GLP-1 Injection Revenue Market Share by Region (2019-2024)
 Table 23. Global GLP-1 Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global GLP-1 Injection Revenue Market Share by Region (2025-2030)
 Table 25. North America GLP-1 Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America GLP-1 Injection Sales by Country (2019-2024) & (K Units)
 Table 27. North America GLP-1 Injection Sales by Country (2025-2030) & (K Units)
 Table 28. North America GLP-1 Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America GLP-1 Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe GLP-1 Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe GLP-1 Injection Sales by Country (2019-2024) & (K Units)
 Table 32. Europe GLP-1 Injection Sales by Country (2025-2030) & (K Units)
 Table 33. Europe GLP-1 Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe GLP-1 Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific GLP-1 Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific GLP-1 Injection Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific GLP-1 Injection Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific GLP-1 Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific GLP-1 Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America GLP-1 Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America GLP-1 Injection Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America GLP-1 Injection Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America GLP-1 Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America GLP-1 Injection Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa GLP-1 Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa GLP-1 Injection Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa GLP-1 Injection Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa GLP-1 Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa GLP-1 Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global GLP-1 Injection Sales (K Units) by Type (2019-2024)
 Table 51. Global GLP-1 Injection Sales (K Units) by Type (2025-2030)
 Table 52. Global GLP-1 Injection Sales Market Share by Type (2019-2024)
 Table 53. Global GLP-1 Injection Sales Market Share by Type (2025-2030)
 Table 54. Global GLP-1 Injection Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global GLP-1 Injection Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global GLP-1 Injection Revenue Market Share by Type (2019-2024)
 Table 57. Global GLP-1 Injection Revenue Market Share by Type (2025-2030)
 Table 58. Global GLP-1 Injection Price (US$/Unit) by Type (2019-2024)
 Table 59. Global GLP-1 Injection Price (US$/Unit) by Type (2025-2030)
 Table 60. Global GLP-1 Injection Sales (K Units) by Application (2019-2024)
 Table 61. Global GLP-1 Injection Sales (K Units) by Application (2025-2030)
 Table 62. Global GLP-1 Injection Sales Market Share by Application (2019-2024)
 Table 63. Global GLP-1 Injection Sales Market Share by Application (2025-2030)
 Table 64. Global GLP-1 Injection Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global GLP-1 Injection Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global GLP-1 Injection Revenue Market Share by Application (2019-2024)
 Table 67. Global GLP-1 Injection Revenue Market Share by Application (2025-2030)
 Table 68. Global GLP-1 Injection Price (US$/Unit) by Application (2019-2024)
 Table 69. Global GLP-1 Injection Price (US$/Unit) by Application (2025-2030)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Novo Nordisk GLP-1 Injection Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Eli Lilly GLP-1 Injection Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. Huadong Medicine Company Information
 Table 81. Huadong Medicine Description and Business Overview
 Table 82. Huadong Medicine GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Huadong Medicine GLP-1 Injection Product
 Table 84. Huadong Medicine Recent Developments/Updates
 Table 85. Innovent Biologics Company Information
 Table 86. Innovent Biologics Description and Business Overview
 Table 87. Innovent Biologics GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Innovent Biologics GLP-1 Injection Product
 Table 89. Innovent Biologics Recent Developments/Updates
 Table 90. Hengrui Medicine Company Information
 Table 91. Hengrui Medicine Description and Business Overview
 Table 92. Hengrui Medicine GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Hengrui Medicine GLP-1 Injection Product
 Table 94. Hengrui Medicine Recent Developments/Updates
 Table 95. Borui Pharmaceuticals Company Information
 Table 96. Borui Pharmaceuticals Description and Business Overview
 Table 97. Borui Pharmaceuticals GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Borui Pharmaceuticals GLP-1 Injection Product
 Table 99. Borui Pharmaceuticals Recent Developments/Updates
 Table 100. Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
 Table 101. Shanghai Benemae Biopharmaceuticals Co., Ltd. Description and Business Overview
 Table 102. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Product
 Table 104. Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments/Updates
 Table 105. CSPC Pharmaceutical Group Company Information
 Table 106. CSPC Pharmaceutical Group Description and Business Overview
 Table 107. CSPC Pharmaceutical Group GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. CSPC Pharmaceutical Group GLP-1 Injection Product
 Table 109. CSPC Pharmaceutical Group Recent Developments/Updates
 Table 110. Hansoh Pharmaceuticals Company Information
 Table 111. Hansoh Pharmaceuticals Description and Business Overview
 Table 112. Hansoh Pharmaceuticals GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Hansoh Pharmaceuticals GLP-1 Injection Product
 Table 114. Hansoh Pharmaceuticals Recent Developments/Updates
 Table 115. Gan & Lee Pharmaceuticals Company Information
 Table 116. Gan & Lee Pharmaceuticals Description and Business Overview
 Table 117. Gan & Lee Pharmaceuticals GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Gan & Lee Pharmaceuticals GLP-1 Injection Product
 Table 119. Gan & Lee Pharmaceuticals Recent Developments/Updates
 Table 120. Sihuan Pharmaceuticals Company Information
 Table 121. Sihuan Pharmaceuticals Description and Business Overview
 Table 122. Sihuan Pharmaceuticals GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Sihuan Pharmaceuticals GLP-1 Injection Product
 Table 124. Sihuan Pharmaceuticals Recent Developments/Updates
 Table 125. Wanbang Biopharma Company Information
 Table 126. Wanbang Biopharma Description and Business Overview
 Table 127. Wanbang Biopharma GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Wanbang Biopharma GLP-1 Injection Product
 Table 129. Wanbang Biopharma Recent Developments/Updates
 Table 130. Imeik Company Information
 Table 131. Imeik Description and Business Overview
 Table 132. Imeik GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Imeik GLP-1 Injection Product
 Table 134. Imeik Recent Developments/Updates
 Table 135. Zhengda Tianqing Company Information
 Table 136. Zhengda Tianqing Description and Business Overview
 Table 137. Zhengda Tianqing GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Zhengda Tianqing GLP-1 Injection Product
 Table 139. Zhengda Tianqing Recent Developments/Updates
 Table 140. Hongyun Huaning Company Information
 Table 141. Hongyun Huaning Description and Business Overview
 Table 142. Hongyun Huaning GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Hongyun Huaning GLP-1 Injection Product
 Table 144. Hongyun Huaning Recent Developments/Updates
 Table 145. Pegbio Company Information
 Table 146. Pegbio Description and Business Overview
 Table 147. Pegbio GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Pegbio GLP-1 Injection Product
 Table 149. Pegbio Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. GLP-1 Injection Distributors List
 Table 153. GLP-1 Injection Customers List
 Table 154. GLP-1 Injection Market Trends
 Table 155. GLP-1 Injection Market Drivers
 Table 156. GLP-1 Injection Market Challenges
 Table 157. GLP-1 Injection Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GLP-1 Injection
 Figure 2. Global GLP-1 Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global GLP-1 Injection Market Share by Type: 2023 & 2030
 Figure 4. Liraglutide Product Picture
 Figure 5. Semaglutide Product Picture
 Figure 6. Tirzepatide Product Picture
 Figure 7. Benaglutide Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global GLP-1 Injection Market Value by Application (2024-2030) & (US$ Million)
 Figure 10. Global GLP-1 Injection Market Share by Application: 2023 & 2030
 Figure 11. Diabetes
 Figure 12. Obesity
 Figure 13. Others
 Figure 14. Global GLP-1 Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global GLP-1 Injection Market Size (2019-2030) & (US$ Million)
 Figure 16. Global GLP-1 Injection Sales (2019-2030) & (K Units)
 Figure 17. Global GLP-1 Injection Average Price (US$/Unit) & (2019-2030)
 Figure 18. GLP-1 Injection Report Years Considered
 Figure 19. GLP-1 Injection Sales Share by Manufacturers in 2023
 Figure 20. Global GLP-1 Injection Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest GLP-1 Injection Players: Market Share by Revenue in GLP-1 Injection in 2023
 Figure 22. GLP-1 Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global GLP-1 Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America GLP-1 Injection Sales Market Share by Country (2019-2030)
 Figure 25. North America GLP-1 Injection Revenue Market Share by Country (2019-2030)
 Figure 26. United States GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe GLP-1 Injection Sales Market Share by Country (2019-2030)
 Figure 29. Europe GLP-1 Injection Revenue Market Share by Country (2019-2030)
 Figure 30. Germany GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific GLP-1 Injection Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific GLP-1 Injection Revenue Market Share by Region (2019-2030)
 Figure 37. China GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America GLP-1 Injection Sales Market Share by Country (2019-2030)
 Figure 45. Mexico GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa GLP-1 Injection Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa GLP-1 Injection Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE GLP-1 Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of GLP-1 Injection by Type (2019-2030)
 Figure 55. Global Revenue Market Share of GLP-1 Injection by Type (2019-2030)
 Figure 56. Global GLP-1 Injection Price (US$/Unit) by Type (2019-2030)
 Figure 57. Global Sales Market Share of GLP-1 Injection by Application (2019-2030)
 Figure 58. Global Revenue Market Share of GLP-1 Injection by Application (2019-2030)
 Figure 59. Global GLP-1 Injection Price (US$/Unit) by Application (2019-2030)
 Figure 60. GLP-1 Injection Value Chain
 Figure 61. GLP-1 Injection Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global GLP 1 Weight Loss Injection Market Research Report 2024
Global GLP 1 Injection Pen Market Research Report 2024
Global GLP 1 Agonist Injection Market Research Report 2024
Global GLP 1 Peptide Drugs Market Research Report 2024
Global GLP 1 based Therapy Market Research Report 2024
Global GLP 1 Weight Loss Drug Market Research Report 2024
Global GLP 1 Drug Peptide API Market Research Report 2024
GLP 1 for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025
GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral GLP 1 Agonist Market Research Report 2024
Global Antidiabetic Glucagon like Peptide 1 Agonists Market Research Report 2025
Global Glucagon Like Peptide 1 GLP 1 Agonists Market Research Report 2025
GLP 1 for Weight Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Agonists for Obesity Market Research Report 2024
Global Electronic Smart Injection Pen Market Research Report 2024
Global GLP 1 Weight Loss Pill Market Research Report 2024
Global GLP 1RA Therapy Market Research Report 2024
GLP Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Agonists for the Treatment of both Diabetes and Obesity Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions